Document text
Principal Investigator: CHERYL LYNN WILLMAN
Organization: UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
Fiscal Year: 2020
Award: $373,749
Funding agency: National Cancer Institute
A vaccine against SARS-CoV2 is badly needed. We have developed a vaccine platform technology based on virus-like particles (VLPs) of RNA phages like MS2, PP7, AP205 and Qß. When displayed multivalently on these bionanoparticles, peptide and protein antigens acquire a high level of immunogenicity. They elicit high titer and long-lived antibody responses to virtually any displayed antigen. Moreover, the VLP platform has rapid response potential to quickly counter emerging threats. Here we describe an approach to the display of SARS-CoV2 epitopes, and tests of their ability to elicit neutralizing and protective antibodies in mice. Our approach consists of three specific aims: In Aim 1, we will Identify candidate vaccine epitopes for SARS-CoV2 and endow them with high immunogenicity by displaying them on VLPs. This virus shares sufficient sequence and structural homology with SARS-CoV1 to allow us to infer likely neutralizing epitopes from knowledge of the targets of its neutralizing antibodies. Accordingly, we describe strategies for display and optimization of spike protein epitopes we predict will elicit antibodies that will separately inhibit two essential steps in virus entry - receptor binding and virus-cell fusion. In Aim 2, we will immunize mice with candidate VLPs and will use ELISA to quantify the resulting antibody responses, testing the reaction of sera with recombinant spike protein and with synthetic peptides representing the chosen epitopes. In Aim 3, the neutralization activity of sera will be tested by plaque reduction neutralization tests in cultured cells. Subsequently, we will vaccinate mice transgenic for human ACE2 (the SARS-CoV2 receptor) and test their abilities to resist the effects of SARS-CoV2 infection.
Terms: <2019 novel coronavirus><2019-nCoV><Adolescent and Young Adult><American Indian><American Indians><Antibodies><Antibody Response><Antigenic Determinants><Antigens><Area><Behavior Conditioning Therapy><Behavior Modification><Behavior Therapy><Behavior Treatment><Behavioral><Behavioral Conditioning Therapy><Behavioral Modification><Behavioral Therapy><Behavioral Treatment><Binding Determinants><Bone Marrow Stem Cell Transplantation><CCSG><Cancer Biology><Cancer Burden><Cancer Center><Cancer Center Support Grant><Cancer Control><Cancer Control Research><Cancer Control Research Program><Cancer Control Science><Cancer Intervention><Cancer Research Programs><Cancer Research Project><Cancer Survivorship><Cancer Treatment><Cancers><Catchment Area><Cell Communication and Signaling><Cell Signaling><Cell fusion><Characteristics><Clinic><Clinical><Clinical Research><Clinical Study><Clinical Trials Network><Communities><Community Networks><Comprehensive Cancer Center><Conditioning Therapy><Cultural Diversity><Cultured Cells><Development><Diagnostic><ELISA><Education and Training><Enzyme-Linked Immunosorbent Assay><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Epitopes><Faculty><Funding><Genetic><Genomics><Geography><Goals><Health><Health Care Professional><Health Care Systems><Health Professional><Health system><Healthcare Systems><Healthcare professional><Hispanic Populations><Hispanics><Human><Immunize><Improve Access><Incidence><Infection><Informatics><Institution><Interdisciplinary Research><Interdisciplinary Study><Intervention><Intervention Strategies><Intervention Studies><Intracellular Communication and Signaling><Investigators><Knowledge><Laboratories><Latino><Latino Population><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Mentors><Mexican><Mice><Mice Mammals><Mission><Modeling><Modern Man><Multiculturalism><Multidisciplinary Collaboration><Multidisciplinary Research><Murine><Mus><NCI Organization><National Cancer Burden><National Cancer Institute><Neutralization Tests><New Mexico><Non-Hispanic><Nonhispanic><Not Hispanic or Latino><Oncologist><Oncology Group><P-30 Protein><P30><P30 Protein><Pattern><Peptides><Pharmacology><Phase><Physicians><Population><Population Sciences><Prevention><Proteins><Provider><Pueblo><Pueblo Race><RNA Bacteriophages><RNA Phages><Reaction><Receptor Protein><Recombinants><Registries><Research><Research Institute><Research Personnel><Research Resources><Research Support><Research Training><Researchers><Resource Sharing><Resources><SARS><SARS coronavirus disease><SARS-CoV disease><SARS-CoV-2><SARS-CoV2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related coronavirus 2><Science><Scientist><Severe Acute Respiratory Syndrome><Severe Acute Respiratory Syndrome CoV disease><Severe Acute Respiratory Syndrome coronavirus disease><Severe acute respiratory syndrome coronavirus 2><Signal Transduction><Signal Transduction Systems><Signaling><Spanish Origin><Structure><Technology><Testing><Therapeutic><Therapeutic Clinical Trial><Therapeutic Intervention><Training><Training Programs><Training and Education><Transgenic Mice><Translating><Tribes><Underrepresented Ethnic Minority><Underrepresented Minority><Underserved Population><Universities><Vaccinated><Vaccines><Virus><Virus-like particle><Wuhan coronavirus><anti-cancer research><anti-cancer therapy><antibody neutralization test><anticancer research><anticancer therapy><base><behavior intervention><behavior measurement><behavioral intervention><behavioral measure><behavioral measurement><biological signal transduction><cancer care><cancer clinical trial><cancer disparity><cancer genetics><cancer health disparity><cancer research><cancer therapy><care delivery><clinical care><clinical translation><design><designing><develop a vaccine><development of a vaccine><developmental><disparities in mortality><disparity in cancer><graduate student><hispanic community><immunogen><immunogenicity><intervention research><intervention therapy><interventional research><interventional strategy><interventional study><interventions research><laboratory facility><malignancy><mortality><mortality disparity><neoplasm/cancer><neuro-oncology><neurooncology><neutralizing antibody><novel><oncology clinical trial><outreach program><programs><ranpirnase><receptor><receptor binding><receptor bound><recruit><research facility><respiratory><response><site targeted delivery><social><synthetic peptide><targeted delivery><treatment research><tumor><under served population><under-representation of minorities><undergraduate><undergraduate student><underrepresentation of minorities><underserved people><vaccine candidate><vaccine development><vaccine formulation><virtual><virus-like nanoparticles><viruslike particle><work group><working group>